Disease as Reason for ERCP Clinical Trial
Official title:
Effect of Different Length of Time for Trainees to Attempt Cannulation on Success Rate of Selective Cannulation During hands-on ERCP Training
Endoscopic retrograde cholangiopancreatography (ERCP) is one of the most difficult
techniques in the field of GI endoscopy. It is necessary for trainees to spend enough time
and perform enough cases to grasp this technique. The methods of ERCP training include
hands-on teaching, training on different kinds of simulators, training on ex-vivo or live
anesthetized porcine stomach models, etc. Supervised hands-on teaching is the standard
method for ERCP training.
Selective cannulation is considered the most difficult and challenging part of learning
ERCP. There is not an optimal time for trainees to attempt cannulation during hands-on ERCP
training. The time used for attempting cannulation by trainees was 5min or 10min in several
centers. In ERCP center of the investigators hospital, 15min was used for trainees to
attempt cannulation for about one year. The incidence of post-ERCP pancreatitis, the major
complication related to cannulation, was 4.0%, which was comparable with previous studies.
The investigators hypothesized that a longer time (15min) for trainees to attempt
cannulation would increase success rate of selective cannulation and help to improve skills
more quickly. At the meantime, with actively verbal or hands-on assistance from the
instructor during performance of trainees, the risk of complications would not increased
with a longer time to attempt cannulation. Here a prospective, endoscopists-blinded,
randomized, controlled study was designed to evaluate the effects of different periods of
time for trainees to attempt selective cannulation on success rate of cannulation,
self-satisfaction of performance and post-ERCP pancreatitis.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01367821 -
Immune Function in Patients With Obstructive Jaundice
|
N/A |